Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
GlaxoSmithKline, LLC.

GlaxoSmithKline, LLC. Recalls

All product recalls associated with GlaxoSmithKline, LLC..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

May 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–22 of 22 recalls

Advair HFA Inhaler (GlaxoSmithKline) – Particle Distribution Issue (2012)

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Class IIILow

FDAOct 24, 2012Nationwide• GlaxoSmithKline, LLC.

Arranon Injection (GlaxoSmithKline) – Impurity Concerns (2012)

Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Class IIModerate

FDAOct 8, 2012Nationwide• GlaxoSmithKline, LLC.

Page 2 of 2Next